alexa
Reach Us +1-217-403-9671
Inactivation of Endotoxin and Lipid A by Nitrogen Gas Plasma Exposure Running title: Inactivation Endotoxin and lipid A | OMICS International
ISSN: 2167-7689
Pharmaceutical Regulatory Affairs: Open Access
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Inactivation of Endotoxin and Lipid A by Nitrogen Gas Plasma Exposure Running title: Inactivation Endotoxin and lipid A

Hideharu Shintani*

Faculty of Science and Engineering, Chuo University, Tokyo, Japan

Corresponding Author:
Hideharu Shintani
Faculty of Science and Engineering Chuo University, 1-13-27, Kasuga, Bunkyo 112-8551, Tokyo, Japan
Tel: +81425922336
Fax: +81425922336
E-mail: [email protected]

Received December 22, 2014; Accepted January 07, 2015; Published January 12, 2015

Citation: Shintani H (2015) Inactivation of Endotoxin and Lipid A by Nitrogen Gas Plasma ExposureRunning title: Inactivation Endotoxin and lipid A. Pharmaceut Reg Affairs 4: 129. doi: 10.4172/2167-7689.1000129

Copyright: © 2015 Shintani H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Pharmaceutical Regulatory Affairs: Open Access

Abstract

The gases plasma from several different gases has shown a sporicidal activity. From these gases, nitrogen gas was most difficult to produce atomic nitrogen radicals. However, these radicals have a high energy, indicating that nitrogen gas plasma could be used to sterilize microorganisms and inactivate endotoxins and lipid A. The sterilization mechanism of nitrogen gas plasma may be the synergistic effect of free radicals such as (OH radical and NO radical) and metastables (N2 or O2 metastable). Thus, the target microorganisms such as bioburden were damaged by degradation, which resulted in death. The biological indicator BI used in this study was Geobacillus stearothermophilus ATCC 7953 at an initial population of 106 CFU/carrier. Sterility assurance level (SAL) of 10-6 was confirmed by using the BI. In addition endotoxins were successfully inactivated by nitrogen gas plasma expossure. More than 5 log reduction of endotoxins could be attained within 30 minutes of nitrogen gas plasma exposure. Lipid A degradation by nitrogen gas plasma exposure was confirmed by LC-MS-MS. Material/functional compatibility was also maintained by nitrogen gas plasma exposure due to shallower penetration depth of 10-20 nm. No deterioration of polymers could be observed by nitrogen gas plasma exposure. Residual gases, if any, are non-toxic. From the above description, it can be said that nitrogen gas plasma sterilization is an alternative future sterilization method.

Keywords

Plasma; Endotoxins; Peptide; Sterilization; Validation

Introduction

It was confirmed that the degree of endotoxin inactivation was more than 5 log reduction in 30 minutes by nitrogen gas plasma (Figure 1) and that by SteradR was around l log reduction [1-3], indicating under experimental conditions, performance characteristics of nitrogen gas plasma was superior to those of SteradR using hydrogen peroxide gas plasma. SteradR is not true gas plasma sterilization [3,4]. Our method of endotoxin inactivation was conducted using nitrogen gas plasma exposure. Concerning Pub Med research or Google research with key words of endotoxin, gas plasma, inactivation or depyrogenation, it is only a few articles to be matched, respectively, indicating gas plasma study of endotoxin inactivation/depyrogenation was very limited [3,5-9].

archive-pharmaceutical-regulatory-affairs-Temperature-dependence-endotoxin

Figure 1: Temperature dependence of endotoxin inactivation by low pressure (LP)

Inactivation of endotoxin

As shown in Figure 1, the higher the temperature, the greater the degree of endotoxin inactivation was obtained. The degree of inactivation was dependent on temperature, which indicates that the inactivation follows the Arrenius equation. Inactivation of endotoxins was confirmed from the results of Limulus ES-II test Wako and Toxinometer ET-2000/J System, Wako. Endotoxins were from LPS (lipopolysaccaride) of E. coli 0111 (Figure 2) and LPS was inoculated onto modified PS (polystylene) evenly at the nm level and thereafter exposed to nitrogen gas plasma. After inactivation of endotoxins by nitrogen gas plasma, no deformation or deterioration of PS of the carrier material was observed, which indicated PS successfully maintained its material functionality (Tables 2 and 3) [3,10-12]. The convenient method of endotoxin inactivation is by dry heat treatment at 250°C for more than a half hour i.e. 45 min or gamma-ray irradiation at 100 kGy after l N NaClO immersion [2]. By these procedures material/functional compatibility may fail to be maintained. However by the treatment with nitrogen gas plasma exposure, endotoxins at more than 5 log reduction can be attained in around 20-30 minutes while simultaneously maintaining material/functional compatibility. In that sense, we could find that nitrogen gas plasma was superior to the conventional procedures of endotoxin inactivation [13].

archive-pharmaceutical-regulatory-affairs-basic-lipopolysaccharide

Figure 2: The basic lipopolysaccharide of E. coli, incorporating lipid A (lower portion of the structure)

Chemical bonding Bonding energy (kL/mol)
H-H 436
C-C 344
C=C 615
C≡C 812
O-O 143
C-O 350
C=O 725
C-H 415
N-H 391
O-H 463

Table 1: Averager bonding energy (kJ/mol)

Sample C(%) O(%) N(%) Si(%)
PS (before treatment) 98.7 1.3
PS (nitrogen gas plasma treatment) 82.9 14.2 2.2 0.7

Table 2: XPS result for PS (polystylene)

Disposition Before of After Treatment to PS CO1 (v/v, ppm) NOx2 (v/v, ppm) HCN3 (v/v, ppm) O34 (v/v, ppm) N2O5 (v/v, ppm)
Low Pressure Beforer <2 <0.5 N.D. N.D. N.D.
Low Pressure After 3.9 1.1 <0.1 <0.05 2.6

Table 3: Analysis of the exhaust gas from PS (polystylene) treated with nitrogen gas plasma

Mechanism of endotoxin inactivation using 1ipid A

The mechanism of endotoxin inactivation was studied by using lipid A and HPLC-MS-MS (High performance liquid chromatography- Mass spectrometry-Mass spectrometry). Synthesized lipid A from Peptide Institute, Inc. (Osaka, Japan) was used for confirmation of the endotoxin inactivation mechanism. This is because lipid A is an active site of endotoxins [14-21]. Chemical structure of endotoxin and lipid A from E. coli is presented in Figures 2 and 3, respectively.

archive-pharmaceutical-regulatory-affairs-Chemical-structure-lipid-A

Figure 3: Chemical structure of lipid A

In Figure 4, M-l peak (negative peak) was observed as 1797 m/e as the mother peak of lipid A. In addition, peaks at 209, 247, 297, 311, 325, 339, 415, 429, 502, 603, 632, 645, 660, 673 and 770 m/e were observed in the non-treated sample which dissolved in DMSO (Figure 4 upper).

archive-pharmaceutical-regulatory-affairs-MS-spectrum-lipid-A

Figure 4: MS spectrum of lipid A before and after nitrogen gas plasma exposure.

However, in the sample treated by the nitrogen gas plasma (Figure 4 middle), these peaks were totally diminished and moreover lower molecular weight peaks significantly decreased. The tiny height of MS peaks remained in the MS spectrum of the plasma-treated sample. This indicates that in the treated sample, any cleavage at several portions in lipid A such as acid amide bondage or ester bondage can be speculated to occur due to the nitrogen gas plasma exposure, As shown in (Figure 4(c)), the mother peak can be observed even in the DMSO solvent alone injection, which means the mother peak may remain in the injection port and/or LC column as an artifact. Thus, due to the appearance of the artifact we unfortunately could not discuss the comparison of the peak height of the mother peak before and after nitrogen gas plasma exposure. However it is clarified that the peaks of around 200 and 700 m/e in lipid A decreased by degradation with nitrogen gas plasma treatment (Figure 4 (a) and (b)).

The mass of peaks at around 200-300 m/e may be single or double chains of fatty acids of C 14 linkage with ester bonding and peaks at around 600,700 m/e may be multiple chains of fatty acids of C14 linkage with ester bonding. The definite portion cleaved in lipid A by nitrogen gas plasma exposure was not clearly clarified [21-23]. It can be speculated that the bonding portion with lower bonding energy such as ester bond or acid amide may be cleaved (C-O, N-H) (Table 1).

Degradation of lipid A by nitrogen gas plasma exposure was observed by atomic force microscopy (AFM) (Figure 5) and X-ray photoelectron spectroscopy (XPS) (Figure 6). By AFM only a trace of lipid A inoculated onto glass remained after nitrogen gas plasma exposure. Moreover, XPS analysis presents an identical result in (Table 2) and an increase in organic nitriding due to increased binding energy at organic nitrogen peaks of around 400 to 404 eV after treatment was observed. Anyhow lipid A at the nm level was almost completely degraded by nitrogen gas plasma exposure (Figure 5).

archive-pharmaceutical-regulatory-affairs-MAFM-analysis-LP

Figure 5: MAFM analysis of LP plasma treated Lipid A (1,25 μg), which was inoculated onto giass.

archive-pharmaceutical-regulatory-affairs-XPS-analysis-LP

Figure 6: XPS analysis of LP plasma treated lipid A (1.25μg), which was inoculated onto glass.

Endotoxin inactivation is essential in implanted medical devices to avoid pyrogen shock in patients which may cause even death in the worst case. In that respect the attainment of endotoxin inactivation at a reduction of more than 5 log by nitrogen gas plasma exposure in 30 minutes has an important meaning for applications to medical devices prior to implantation into the human body. It has significant benefit to patients requiring medical devices implantation by ensuring endotoxin-free devices to prevent disease conditions associated with contaminated endotoxins such as pyrogen shock. The authority requires less than 20 EU (endotoxin unit) reduction of endotoxin together with maintaining material/functional compatibility, so according to our method authority’s requirement can be achieved in success without any difficulty.

As we have confirmed the destruction of spore-type microorganisms and endotoxin inactivation by nitrogen gas plasma exposure, we will conduct experiments on prion inactivation by nitrogen gas plasma exposure without carrier material deterioration [3,4]. According to our preliminary experiment normal prions were totally destroyed as had been the case with spores and endotoxins. From this we speculate abnormal prions causing Creutzfeldt-Jakob disease to humans would also be destroyed without deteriorating support material using nitrogen gas plasma exposure, which would bring significant benefits to our life. We speculate abnormal prions can destroy in success maintaining material functionality because abnormal and normal prions differs only the higher dimension structure and primary amino acids sequence is identical. Abnormal prion has more beta sheet structure than normal prion. We already confirmed myoglobin degradation which enriches beta sheet in that third structure by the nitrogen gas plasma exposure maintaining material/functional compatibility. Additionally, we will conduct experiment on the validation of the sterilization of the interior of the endoscope, expensive artificial heart valves, expensive surgery devices used for brain or nerves and so on by nitrogen gas plasma to attain benefits for patients using these devices in the coming study to avoid iatrogenic diseases caused at health care facilities.

Conclusion

Endotoxin inactivation can be successfully conducted after nitrogen gas plasma exposure for 30 minutes. After 30 minutes exposure, more than 5 log reduction of endotoxin can be confirmed. The authority requires less than 20 EU (endotoxin unit) reduction of endotoxin together with material/functional compatibility, so according to our method authority’s requirement can be achieved in success without any difficulties.

Lipid A is an active site of endotoxin. Lipid A degradation after nitrogen gas plasma exposure was observed using high performance liquid chromatography-mass spectrometry. From the HPLC-MS-MS data, fragmentation and dergradation of lipid A by nitrogen gas plasma was confirmed. Normal prion and myoglobin degradation was also confirmed.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 12284
  • [From(publication date):
    March-2015 - Dec 13, 2018]
  • Breakdown by view type
  • HTML page views : 8483
  • PDF downloads : 3801
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

streamtajm

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7